Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3278 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Cayenne secures $15 million in series C financing

Other participating investors include SplitRock Partners, MB Venture Partners and a group of accredited private individuals. Stephen Campe, managing director of IGC, has joined Cayenne’s board in connection

Invacare names new CFO

In his new role Mr Gudbranson will be responsible for all aspects of Invacare’s finance, treasury, internal audit, investor relations, and information technology functions. Mr Gudbranson replaces Gregory

Emergent acquires Avanir’s anthrax antibodies

AVP-21D9 is a human monoclonal antibody product candidate that is being developed as an intravenous treatment for patients with symptoms of anthrax disease following exposure to Bacillus anthracis.

Nfocus acquires StarFire Medical

The assets acquired include products such as the DSB (Detachable Silicone Balloon) and the NDSB (Non-Detachable Silicone Balloon), also known as the Endeavor Balloon Catheter, both of which

Single European pricing likely to be delayed

The complexity of pricing systems and varied reimbursement rates for drugs, coupled with different purchasing powers and healthcare systems across Europe pose a formidable obstacle for the adoption